[1]Shibata S, Uchida S. Hyperkalemia in patients undergoing hemodialysis: its pathophysiology and management[J]. Ther Apher Dial, 2022, 26(1): 3-14.
[2]Bansal S, Pergola P E. Current management of hyperkalemia in patients on dialysis[J]. Kidney Int Rep, 2020, 5(6): 779-789.
[3]De Rooij E N M, Dekker F W, Le Cessie S, et al. Serum potassium and mortality risk in hemodialysis patients: a cohort study[J]. Kidney Med, 2022, 4(1): 100379.
[4]Kovesdy C P, Regidor D L, Mehrotra R, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients[J]. Clin J Am Soc Nephrol, 2007, 2(5): 999-1007.
[5]Weiss J N, Qu Z L, Shivkumar K. Electrophysiology of hypokalemia and hyperkalemia[J]. Circ Arrhythm Electrophysiol, 2017, 10(3): e004667.
[6]Ma L Q, Zhang X X, Chen H J. TWIK-1 two-pore domain potassium channels change ion selectivity and conduct inward leak sodium currents in hypokalemia[J]. Sci Signal, 2011, 4(176): ra37.
[7]Skogestad J, Aronsen J M. Hypokalemia-induced arrhythmias and heart failure: new insights and implications for therapy[J]. Front Physiol, 2018, 9: 1500.
[8]Xu Q D, Xu F H, Fan L, et al. Serum potassium levels and its variability in incident peritoneal dialysis patients: associations with mortality[J]. PLoS One, 2014, 9(1): e86750.
[9]Dashputre A A, Potukuchi P K, Sumida K, et al. Predialysis potassium variability and postdialysis mortality in patients with advanced CKD[J]. Kidney Int Rep, 2021, 6(2): 366-380.
[10]Yamaguchi K, Kitamura M, Otsuka E, et al. Association between annual variability of potassium levels and prognosis in patients undergoing hemodialysis[J]. Clin Exp Nephrol, 2023, 27(10): 873-881.
[11]Zhang H X, Liu J, Liu X, et al. Pre- to post-dialysis potassium gradient and mortality in patients on hemodialysis: a propensity-matched analysis[J]. Ther Apher Dial, 2025, 29(2): 189-199.
[12]Zhao X J, Hou F F, Liang X L, et al. High facility-level serum potassium variability associated with mortality in hemodialysis patients: results from Chinese Dialysis Outcomes and Practice Patterns Study(DOPPS)[J]. Ren Fail, 2023, 45(1): 2211157.
[13]Mercadal L, Lambert O, Couchoud C, et al. Prescription patterns of dialysate potassium and potassium binders and survival on haemodialysis-the French renal epidemiology and information network registry[J]. Nephrol Dial Transplant, 2021, 36(1): 151-159.
[14]He H D, Wu J J, Lu W, et al. A multicenter study of hemodialysis using individualized dialysate potassium concentrations[J]. Ann Palliat Med, 2021, 10(12): 12218-12229.
[15]Fishbane S, Ford M, Fukagawa M, et al. A phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia[J]. J Am Soc Nephrol, 2019, 30(9): 1723-1733.
|